Concepedia

Salim Shafeek

SS

5

Publications

497

Citations

5

H-Index

2019

Active since

Affiliations

University of Birmingham(Current)

Worcestershire Acute Hospitals NHS Trust

East Kent Hospitals University NHS Foundation Trust

King's College London

The Royal Wolverhampton NHS Trust

Salim Shafeek is an author at University of Birmingham specializing in hematology, oncology, and radiation oncology.

Top concepts

Publications per year

2019–2024

5

Publications

5

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 375 citations · Full text

, , +6

Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia

Helen Parry, Graham McIlroy, Rachel Bruton et al. · Journal of Hematology & Oncology · 2022 · 35 citations · Full text

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

Graham Jackson, Faith E. Davies, Charlotte Pawlyn et al. · Haematologica · 2020 · 33 citations · Full text

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 31 citations · Full text

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study

Adrian Shields, Srinivasan Venkatachalam, Salim Shafeek et al. · Clinical & Experimental Immunology · 2021 · 23 citations · Full text

Rows per page

1–5 of 5